| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |